Argos Therapeutics Inc (ARGSQ)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

4233 TECHNOLOGY DR DURHAM, NC 27704

Argos Therapeutics, Inc. is a biopharmaceutical company. The company is focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform.

Data as of 2019-12-02 20:51:23 -0500
Market Cap567.463 Thousand Shares Outstanding10.587 Million Avg 30-day Volume
P/E Ratio Dividend Yield EPS-1.742
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low0.25 / 0.019 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud
View SEC Filings from ARGSQ instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) No data
Funds Holding: 1 0 1 (0.06%) No data
13F shares: 12.54 Thousand 0 12.54 Thousand No data
% Ownership No data
New Positions: 1 1 No data
Increased Positions No data
Closed Positions No data
Reduced Positions No data
Total Calls No data
Total Puts No data
PUT/CALL Ratio No data No data
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ARGSQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARGSQ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HARRELSON LORI R. VICE PRESIDENT OF FINANCE

  • Officer
11,776 2018-04-25 0

NICOLETTE CHARLES A. CSO AND VICE PRESIDENT OF R&D

  • Officer
20,056 2018-04-25 0

ABBEY JEFFREY D CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
25,450 2018-04-25 0

KATZ RICHARD D VICE PRESIDENT AND CFO

  • Officer
9,697 2018-04-25 0

PHARMSTANDARD INTERNATIONAL S.A.

JOINT STOCK CO PHARMSTANDARD

  • 10% Owner
13,142,784 2017-10-31 0

MORRISON RICHARD G

  • Director
0 2017-09-26 0

VAN DEVENTER SANDER

  • Director
0 2017-01-19 0

BIRNER HUBERT

  • Director
0 2017-01-19 0

WINTERBOTTOM JOAN CHIEF HUMAN RESOURCES OFFICER

  • Officer
47,248 2017-01-19 0

CAREY ROBERT

  • Director
0 2017-01-19 0

ALLEN LEE F MD PHD CHIEF MEDICAL OFFICER

  • Officer
7,378 2017-01-19 0

KROL IGOR

  • Director
0 2017-01-19 0

SNYDERMAN RALPH

  • Director
573 2016-12-31 0

MTIBELISHVILY IRACKLY

  • Director
14,895 2016-12-31 0

PETROV ANDREI VLADIMIROVICH

  • Director
10,530 2016-09-30 0

VAN HOLLE PHILIPPE MARIE MARCEL JOSEPH

  • Director
50,955 2016-09-30 0

FORARGOS B.V.

  • 10% Owner
6,199,961 2016-08-02 0

VINOGRADOV ALEXEY ALEXANDROVICH

  • Director
  • 10% Owner
3,367 2016-03-31 0

MIESOWICZ FREDERICK COO

  • Officer
36,843 2016-01-08 0

LAMARRE JEAN

  • Director
2,500 2015-08-25 0

PLESSINGER DOUGLAS C. SEE REMARKS

  • Officer
0 2015-06-17 0

UNDERDOWN BRIAN J.

  • Director
0 2015-06-17 0

COOPERATIEVE AAC LS U.A.

FORBION CO-INVESTMENT II COOPERATIEF U.A.

  • 10% Owner
2,450,144 2014-02-12 0

JAIC USSII NO. 1, LLC

  • 10% Owner
0 2014-02-06 0

LCC LEGACY HOLDINGS INC.

LUMIRA CAPITAL I LIMITED PARTNERSHIP

LUMIRA CAPITAL I QUEBEC LIMITED PARTNERSHIP

  • 10% Owner
0 2014-02-06 0

GREEN CROSS CORP.

  • 10% Owner
0 2014-02-06 0

TFG USA, LLC

  • 10% Owner
36,183 2014-02-06 0

STRIKER ASIA OPPORTUNITIES FUND CORP

  • 10% Owner
0 2014-02-06 0

AURORA VENTURES II LLC

HARBINGER AURORA QP VENTURE FUND LLC

HARBINGER AURORA VENTURE FUND LLC

AV II ARGOS ENRICHMENT, LLC

  • 10% Owner
0 2014-02-06 0

MIZUHO CAPITAL NO. 3 LIMITED PARTNERSHIP

  • 10% Owner
43,325 2014-02-06 0

GRYSKA DAVID W

  • Director
0 2014-02-06 0

KYOWA HAKKO KIRIN CO LTD

  • 10% Owner
70,406 2014-02-06 0

MORNINGSIDE VENTURE INVESTMENTS LTD

  • 10% Owner
0 2014-02-06 0

TVM V LIFE SCIENCE VENTURES GMBH & CO KG

TVM V LIFE SCIENCE VENTURES MANAGEMENT GMBH & CO. KG

FISCHER STEFAN

GOLL ALEXANDRA

POLACK AXEL

  • 10% Owner
0 2014-02-06 0

CAISSE DE DEPOT ET PLACEMENT DU QUEBEC

  • 10% Owner
0 2014-02-06 0

INTERSOUTH AFFILIATES V LP

INTERSOUTH PARTNERS IV LP /NC

INTERSOUTH PARTNERS V, L.P.

  • 10% Owner
0 2014-02-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments